Ascendis Pharma
Ascendis Pharma is a global biopharmaceutical company that utilizes its proprietary TransCon technology platform to develop new therapies. The company focuses on advancing a pipeline of product candidates within the fields of endocrinology rare diseases and oncology. Its primary goal is to improve the safety, efficacy, and convenience of treatments for patients worldwide.
Visit websiteHellerup, Denmark
Biopharmaceutical
Healthcare
Oncology
Endocrinology
Funding summary
- Total raised
- €54.5M
- Funding rounds
- 1
Investors in Ascendis Pharma
Investors on record for Ascendis Pharma. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Ascendis Pharma?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors